Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Operating Expenses | 3,263 | 2,089 | 1,208 | 689 | 408 |
| Operating Income | -3,263 | -2,089 | -1,208 | -689 | -408 |
| Other Income | 10 | 14 | -77 | -312 | -31 |
| Pre-tax Income | -3,253 | -2,075 | -1,284 | -1,002 | -439 |
| Net Income Continuous | -3,253 | -2,075 | -1,284 | -1,002 | -439 |
| Net Income | $-3,253 | $-2,075 | $-1,284 | $-1,002 | $-439 |
| EPS Basic Total Ops | -0.08 | -0.05 | -0.08 | -0.13 | -0.05 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | -0.08 | -0.12 | -0.05 |
| EPS Diluted Total Ops | -0.08 | -0.05 | -0.08 | -0.13 | -0.05 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | -0.08 | -0.12 | -0.05 |
| EBITDA(a) | $-3,231 | $-2,059 | $-1,186 | $-669 | $-388 |